Gene · 22918
Papers1,470
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,470
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions. | Inflamm Res | 2026 | 41741777 | PubTator, text mining | PubMed |
| GALNT10 Affects O-Glycosylation of IGFBP7 to Promote Tumor Vascular Remodeling and Metastasis of Ovarian Cancer. | Adv Sci (Weinh) | 2026 | 41637621 | PubTator, text mining | PubMed |
| A novel peptide blocking CD93/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy. | Pharmacol Res | 2026 | 41628738 | PubTator, text mining | PubMed |
| CD93 and endothelial cells as therapeutic targets in podocytopathies. | Nat Rev Nephrol | 2026 | 41611897 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Engineered Small Extracellular Vesicles Targeting Tumor-Associated Endothelial Cells to Effectively Remodel the Glioma Microenvironment. | Adv Sci (Weinh) | 2026 | 41566763 | PubTator, text mining | PubMed |
| Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome. | Sci Transl Med | 2026 | 41533775 | PubTator, text mining | PubMed |
| Capillary Endothelial Cell Subtypes in the Lung: Markers and Response to Developmental Lung Injury. | Am J Respir Cell Mol Biol | 2026 | 40845320 | PubTator, text mining | PubMed |
| Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer. | Mol Oncol | 2026 | 40761160 | PubTator, text mining | PubMed |
| Unraveling hematopoietic stem cell ontogeny through single-cell multi-omics approaches. | Front Cell Dev Biol | 2025 | 41358001 | PubTator, text mining | PubMed |
| Interpretable machine learning applied to high-dimensional salivary proteomics accurately classifies pediatric inflammatory bowel diseases. | medRxiv | 2025 | 41282744 | PubTator, text mining | PubMed |
| C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration. | Res Sq | 2025 | 41282250 | PubTator, text mining | PubMed |
| Efferocytosis-related signatures identified via Single-cell analysis and machine learning predict TNBC outcomes and immunotherapy response. | Sci Rep | 2025 | 41198835 | PubTator, text mining | PubMed |
| CLL, together with C1qR, suppresses WSSV infection by regulating the activation of Dorsal. | J Virol | 2025 | 41081512 | PubTator, text mining | PubMed |
| Multi-omics reveals efferocytosis-related hub genes as biomarkers for ustekinumab response in colitis. | Front Immunol | 2025 | 41050686 | PubTator, text mining | PubMed |
| Gene Expression Factors Associated with Rubella-Specific Humoral Immunity After a Third MMR Vaccine Dose. | Viruses | 2025 | 41012582 | PubTator, text mining | PubMed |
| The Precision Paradigm in Periodontology: A Multilevel Framework for Tailored Diagnosis, Treatment, and Prevention. | J Pers Med | 2025 | 41003143 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Spatial Transcriptomic Analysis Reveals a Pathological Niche Formed by FAP+ Fibroblasts, Immune, and Endothelial Cells in Psoriatic Lesions. | Clin Cosmet Investig Dermatol | 2025 | 40963886 | PubTator, text mining | PubMed |
| Spatial Single-Cell Atlas Reveals KSHV-Driven Broad Cellular Reprogramming, Progenitor Expansion, Immune and Vascular Remodeling in Kaposi's Sarcoma. | bioRxiv | 2025 | 40949967 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22918/papers?page=2